Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.75
-0.4600-0.90%
Post-market: 50.750.00000.00%19:59 EDT
Volume:3.18M
Turnover:160.96M
Market Cap:102.65B
PE:16.23
High:50.92
Open:50.83
Low:50.29
Close:51.21
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.62
T/O Rate:0.16%
Dividend:1.82
Dividend Rate:3.58%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.35
PE(LYR):13.58

Loading ...

A 42% Risk Reduction—and an 18% Stock Drop

Bellwether Stocks Movement
·
Yesterday

Earning Preview: GlaxoSmithKline PLC revenue is expected to increase by 5.09% this quarter, and institutional views are bearish

Earnings Agent
·
Oct 21

GSK's New Drug Sparks Competition in Hepatitis B Functional Cure Race as Domestic Pharmaceutical Companies Vie for Billion-Yuan Market

Deep News
·
Oct 23

GSK Rises Thursday, Outperforms Market

Dow Jones
·
Oct 23

GlaxoSmithKline (GSK) Receives a Sell from J.P. Morgan

TIPRANKS
·
Oct 22

GSK’s ViiV announce real-world evidence from OPERA cohort using Cabenuva

TIPRANKS
·
Oct 21

Hutchmed Closes GSK License Deal for KRAS-EGFR Cancer Therapy

MT Newswires Live
·
Oct 21

Movement Alert|GlaxoSmithKline PLC Overnight Decline 3.61%, Jemperli FDA accelerated approval draws a cautious market response

Market Focus
·
Oct 21

GSK’s Hibsago approved by FDA for treatment of CHB

TIPRANKS
·
Oct 21

Movement Alert|GlaxoSmithKline PLC Intraday Rise 3.21% in Regular Trading, Jemperli Wins FDA Accelerated Approval for Some Advanced Rectal Cancer Patients

Market Focus
·
Oct 21

One Failed Endpoint Just Erased Most of EyePoint’s Value

Bellwether Stocks Movement
·
Oct 20

RBC Capital Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Oct 20

AnaptysBio notes Jemperli approved in U.S. for locally advanced rectal cancer

TIPRANKS
·
Oct 20

GSK confirms FDA approval of Jemperli for certain rectal cancers

TIPRANKS
·
Oct 20

Jefferies Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Oct 19

GSK Says Lung-Cancer Drug Shows Benefits in Global Trial

Dow Jones
·
Oct 19

GSK announces global data for risvutatug rezetecan

TIPRANKS
·
Oct 19

Novartis’ Pipeline Is Cracking—And The Stock Isn’t

Bellwether Stocks Movement
·
Oct 17

From Algorithms To Oncology: Why IAM Jumped On Day One

Bellwether Stocks Movement
·
Oct 16

From One Brain Controlling Multiple Machines to Ten Thousand Drones Flying in Formation: China's Manufacturing Sector Demonstrates System-Level Capabilities

Deep News
·
Oct 16